Dermatology Lecture 12 PDF
Document Details
Uploaded by SelfSatisfactionFlugelhorn5899
Mansoura University
Tags
Summary
This document covers various dermatological conditions, including Erythema Multiforme, Erythema Nodosum, drug reactions, epidermal necrolysis, and pemphigus vulgaris. It details definitions, etiologies, clinical presentations, and treatment approaches for each condition. The document also includes questions and answers related to the topics.
Full Transcript
# Dermatology ## Lecture 12: Erythema Multiforme & nodosum & Drug reactions & Epidermal necrolysis & Pemphigus vulgaris ### Erythema Multiforme (E.M.) **Def:** - Acute self-limited skin disease characterized by target or iris lesion. **Etiology:** - Immune mediated common reaction pattern to...
# Dermatology ## Lecture 12: Erythema Multiforme & nodosum & Drug reactions & Epidermal necrolysis & Pemphigus vulgaris ### Erythema Multiforme (E.M.) **Def:** - Acute self-limited skin disease characterized by target or iris lesion. **Etiology:** - Immune mediated common reaction pattern to various antigenic stimuli such as: - **Infections:** - **Viral:** herpes simplex (The most common precipitating factor) - **Mycoplasma infection**. - **Drugs** - **Idiopathic** **E.M. has two subtypes: E.M. minor & E.M. major.** ### Erythema Multiforme (E.M.) **E.M. minor:** **Prodroma:** - Is absent or mild. **Skin lesions:** - **without** mucous membrane involvement. **Clinical Picture:** **Skin lesions:** - **Distribution:** - Bilateral & symmetrical distribution on the extensor surface of extremities (hands, feet, forearm). - Face, neck and trunk are less commonly affected. - **Shape:** - Polymorphic - The most characteristic is the target or iris lesion. **Target or Iris Lesion:** - Is circular with three zones (alternating dark and light): - **Central:** cyanotic or purpuric, Vesicle or bulla may occur in the centre - **Pale Ring** - **Periphery:** erythematous & Edematous area surrounding the pale ring - **Asymptomatic but** there may be itching or burning sensation. ### Erythema Multiforme (E.M.) **E.M. major:** - **Skin lesions** with involvement of mucous membrane - **Systemic symptoms** are always present - (Fever, occasionally arthralgia (constitutional +ve) or pneumonia) - **Skin lesions:** as E.M minor or severe wide-spread Vesiculo-bullous eruption - **Mucous membrane lesions:** - **Oral:** erosions, vesicles and bullae - **Lips:** haemorrhagic crusts - **Eyes:** conjunctivitis, corneal ulcer - **Nasal** - **uretheral and anal mucosa** may be inflammed and eroded ### Erythema Nodosum **Def:** - Inflammation of subcutaneous fat (panniculitis) presents as an acute self-limited painful nodular erythematous eruption. - It is an allergic reaction to: - **Infections:** - **Bacteria:** streptococci - **Viruses:** hepatitis, infectious mononucleosis, upper respiratory tract infection - **Mycobacteria:** leprosy - **Drugs:** sulfa, contraceptive pill.. - **Others:** Sarcoidosis, malignancy, (enteropathies) IBD. - **Idiopathic:** 30-50% **Prodroma:** URT infections **General:** - Fever, malaise, arthritis, or arthralgia **Skin lesion:** - Painful tender, bilateral, Shiny red nodules - Healing: Bruise colour changes. - **site:** Chin of tibia (commonest), occasionally forearm and thigh - Show bruise-like colour changes during regression. ### Course: - E.M. usually fades within 2-4 weeks - E.M. tends to recur (in 30 % of cases ) - Spontaneous resolution in about 2-6 weeks without residual scarring, - However, recurrence may occur ### Treatment:: - **Elimination of cause** - **Symptomatic and supportive** - **Prevention (Recurrent cases):** - Oral acyclovir (400 mg twice daily for 6 months) to prevent recurrence of herpes associated E.M - **Treatment of the cause.** - **Bed rest and supportive bandages.** - **Non-steroidal anti-inflammatory drugs (NSAIDs)** - **potassium iodide for 2 weeks in severe cases** # Drug Reactions **Definition:** Drug reaction is harmful, unintended, response to drug in therapeutic dose. **Mechanism:** allergic or non-allergic **Clinical picture:** - **Severe life –threatening drug reactions:** - **Anaphylactic shock:** pallor, hypotension, bronchospasm, angioedema - **Erythroderma** - **Epidermal necrolysis:** Stevens-Johnson Syndrome & Toxic epidermal necrolysis (TEN) *Page 7* - **Drug reaction with eosinophilia and systemic symptoms (DRESS):** skin rash, facial oedema, eosinophilia, lymphadenopathy and organ affection (liver, kidney,..) **Other forms of drug reaction:** 1. **Urticaria (Penicillin, aspirin)** 2. **Exanthematous rash:** - Red maculopapular rash (like measles) 3. **Photosensitivity (Psoralen, Tetracycline).** 4. **Vascular eruption or purpuric lesion** 5. **Lichenoid eruption** 6. **Bullous eruption** 7. **Acne-form eruption:** inflammatory papules or pustules that have a follicular pattern - (corticosteroids, ACTH, Bromide, lodide, Isoniazide) 8. **Pigmentation:** antimalarial, phenothiazine, gold 9. **Alopecia (following chemotherapy)** 10. **Fixed drug eruption:** - It characterisitically recurs in the same sites each time the drug is administered. - Common drugs causing fixed eruption are: Sulfonamides, NSAIDs - **Clinical picture:** - Well-defined round or oval plaque of erythema & oedema. Bulla may develop on the top - Healed lesion is hyperpigmented (dark brown to violet) - **Common sites involved are:** lips, anogenital area (glans penis), but can occur anywhere. ### Diagnosis of drug reactions: 1. **abrupt onset Symmetric cutaneous eruption** 2. **History of drug intake.** 3. **De-challenge test:** The eruption improves when the suspected drug is stopped. (clear in 2 weeks on withdrawal) 4. **Re-challenge (oral provocation test))** ### Treatment of drug reactions: - **Elimination of the offending drug** - **Symptomatic treatment:** - **Antihistamines.** - **Topical steroid.** - **Systemic steroids in severe cases.** # Epidermal Necrolysis ### (Stevens-Johnson Syndrome & Toxic epidermal necrolysis) **Definition:** - Acute, drug induced, life-threatening mucocutaneous reactions - Characterized by extensive necrosis and detachment of the epidermis. - The two conditions differ only in the percentage of body surface area affected: - **Stevens-Johnson Syndrome (SJS):** less than 10% - **SJS-TEN overlaps:** 10-30% - **Toxic epidermal necrolysis (TEN):** more than 30% **Prodroma:** - Of URT symptoms; High fever, painful skin and weakness. **Clinical features:** - **Skin:** - Erythematous and purpuric macules on trunk and proximal limbs → flaccid blisters → epidermal detachment and large confluent oozing erosions - Nikolsky sign is positive (firm sliding pressure on normal appearing skin → detachment of intact superficial epidermis) - **Sites:** mainly localized to face,upper trunk, and hands - **Mucous membrane:** - Involvement in 90% of cases ( always at least two sites) - Erythema and painful erosions of buccal, ocular, and genital mucosa - **Visceral involvement:** - Is possible (pulmonary, GIT, renal) **Prognosis:** - Mortality rate is up 25%. - Death may be due to sepsis, electrolyte imbalance or organ failure. **Ttt:** - Early (immediate) withdrawal of suspected drugs. - Rapid initiation of supportive care in intensive care burn unit. # Pemphigus vulgaris **Definition:** - Autoimmune disease in which autoantibodies are formed against intercellular bridges of the prickle cell layer. - This results in acantholysis and formation of intraepidermal bullae. - Incidence: Rare chronic disease, usually affects adults. (4-5th decades) **Clinical picture:** - **Lesion:** - Characterized by flaccid bullae arising upon normal skin and mucous membranes. - The bullae rupture easily leaving painful erosions & crusts. - Painful erosions on mucous membrane. - **Complication:** Infection, fluid & electrolyte imbalance may result in death. - **Nikolsky sign is positive** - **Sites:** commonly involved are scalp, intertriginous area and umbilicus, but in severe cases any site can be involved. **Treatment:** - Refer to dermatologist - Systemic steroids & immunosuppressive (cytotoxic) drugs. # Case Scenarios - **Case 1 scenario** - Mona is a 40-year-old lady with erythematous asymptomatic skin lesions on hands and feet of two weeks duration. - One week before the appearance of these lesions she had common cold and developed sores and crusts on lips. - **Skin exam:** - MONA was diagnosed to have erythema multiforme after herpes simplex infection - **Case 2 scenario** - Ola is a 29-year- old lady presented to emergency room with a painful,expanding and sloughing rash. - She was recently diagnosed to have a urinary tract infection, on treatment with Bactr. - **skin examination** - Erythematous erosions, mainly localized on the face, upper trunk and hands - Lesions began as flaccid blisters - **Answer:** - Ola was diagnosed to have severe drug reaction of Epidermal Necrolysis spectrum. - This spectrum includes Stevens Johnson Syndrome and toxic epidermal necrolysis. # Questions **Q: What is the characteristic lesion of erythema multiform?** - **A:** target lesion **Q:What is the characterestic lesion of erythema nodosum?** - **A:** nodules **Q:Mention two life threatening drug reactions.** - **A:** DRESS - **SIS and TEN Spectrum** **Q: What is the primary lesion of pemphigus vulgaris?** - **A:** flacid bullae **What is the difference between a vesicle and a bulla?** - **a)** Depth (distinguishes erosion and ulcer) - **b)** diameter - **c)** Etiology (morphologic terms, not etiologic) - **d)** Location (both can occur anywhere) - **e)** Presence of hemorrhage (either vesicles or bullae may be filled with blood) - **Answer:** B **1- bullae are expected finding in:** - **a)** psoriasis - **b)** pityriasis rosea. - **c)** pityriasis alba. - **d)** lupus vulgaris. - **e)** pemphigus. - **ANS: 1-e** **2- Target lesion occurs in:** - **a)** Pemphigus vulgaris. - **b)** Acne vulgaris. - **c)** Erythema a multiforme. - **d)** Lichen planus - **e)** Acne vulgaris - **A:** c **3- Erythema multiforme is characterized by:** - **a)** Shins of the tibiae are the most common sites - **b)** Could be precipitated by herpes simplex infection - **c)** Painful subcutaneous nodular erythematous eruption - **d)** Regress with bruise like colour changes. - **e)** Infectious disease - **ANS: 3-b**